Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant FOLFIRINOX and Chemoradiation in Localized Pancreatic Head Adenocarcinoma
NCT01677988Phase 2Terminated
- Sponsor
- Medical University of South Carolina
- Start
- Jul 2012
- Primary completion
- Oct 2015
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of FOLFIRINOX in pancreatic adenocarcinoma (PDAC), sponsored by Medical University of South Carolina. Started Jul 2012; status: terminated.
02
Drugs
FOLFIRINOX
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01677988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01677988.